BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 5291630)

  • 1. Corticosteroid bioavailability assays. Correlation with a clinical study.
    Burdick KH
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):19-23. PubMed ID: 5291630
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a new corticosteroid, fluocinonide, in a scientifically designed base.
    Burdick KH
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):24-31. PubMed ID: 5291631
    [No Abstract]   [Full Text] [Related]  

  • 3. Design of the optimal topical system for fluocinonide.
    Reinstein J; Ostrenga J; Haleblian J; Shastri S; Poulsen B; Katz M
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):Suppl 67:13-8. PubMed ID: 5291642
    [No Abstract]   [Full Text] [Related]  

  • 4. The activity of fluocinonide on diseases and healthy skin in comparison with other topical corticosteroids.
    Kalkoff KW
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):51-6. PubMed ID: 5291633
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluocinonide--a new topical corticosteroid. Clinical evaluation.
    Mendelson CG
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):63-5. PubMed ID: 5291635
    [No Abstract]   [Full Text] [Related]  

  • 6. Report on clinical experience with fluocinonide cream.
    Bosse K
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):57-60. PubMed ID: 5291634
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind clinical trial comparing fluocinonide FAPG cream with flumethasone pivalate cream.
    Baran R
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):79-81. PubMed ID: 5291638
    [No Abstract]   [Full Text] [Related]  

  • 8. The croton oil inflammation suppression assay as a measure of topical corticosteroid potency.
    Ortega E; Rodriguez C; Burdick KH; Place VA; Gonzales L
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):95-7. PubMed ID: 5291641
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with fluocinonide in 90 out-patients.
    Eichenberger H
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):87. PubMed ID: 5291640
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of fluocinonide and flumethasone in the treatment of 6 cases of psoriasis.
    Bigliardi P
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):82-3. PubMed ID: 5291639
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of fluocinonide and betamethasone in the treatment of psoriasis and eczema.
    Portnoy B
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):72-3. PubMed ID: 5291636
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative double-blind clinical trial of fluocinonide and betamethasone valerate.
    Sarkany I
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):70-1. PubMed ID: 4947904
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of plasma cortisol in patients treated with fluocinonide cream with either open or occlusive application.
    Pozzo G; Prandini BD
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):40-2. PubMed ID: 5291632
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of two fluorinated topical steroids in the treatment of common eczemas, on a once a day treatment schedule.
    Neumann L
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):74-6. PubMed ID: 5291637
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacology of locally applied glucocorticoids.
    Raab WP
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):32-9. PubMed ID: 5004480
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluocinonide in FAPG base: a review of its therapeutic efficacy in inflammatory dermatoses.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1974; 7(5):337-43. PubMed ID: 4604483
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with fluocinonide FAPG].
    Reiffenstuhl B; Wolf D
    Wien Med Wochenschr; 1973 Sep; 123(38):555-6. PubMed ID: 4270843
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidermolysis bullosa hereditaria. Clinical trial with fluocinonide FAPG 0.05 percent in five cases.
    De Brito Caldeira J; Lacerda e Costa MH
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):88-90. PubMed ID: 4112269
    [No Abstract]   [Full Text] [Related]  

  • 19. Contact dermatitis from stearyl alcohol and propylene glycol in fluocinonide cream.
    Shore RN; Shelley WB
    Arch Dermatol; 1974 Mar; 109(3):397-9. PubMed ID: 4814942
    [No Abstract]   [Full Text] [Related]  

  • 20. Corticosteroid ointments: comparison by two human bioassays.
    Burdick KH; Haleblian JK; Poulsen BJ; Cobner SE
    Curr Ther Res Clin Exp; 1973 May; 15(5):233-42. PubMed ID: 4196783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.